Merit Medical publishes transcript of Q2 2026 earnings call
MMSI•Q2 results and margin performance
Merit Medical hosted its Q2 2026 earnings call with CEO Martha Aronson, CFO Raul Parra, Chief Legal Officer Brian Lloyd, and analysts.
- Revenue was USD 418.8 million.
- GAAP revenue was up 10% year over year; constant-currency revenue was up 9%.
- Organic constant-currency revenue was up 9%, the strongest in three years.
- Non-GAAP operating margin was 22.6%; tariff refunds lifted results.
- Excluding refunds, operating margin was 20.9% and EPS was USD 1.10.
Updated full-year and third-quarter outlook
Merit Medical raised its 2026 outlook:
- Constant-currency revenue growth: 6.9% to 7.6%
- Organic revenue growth: 6.9% to 7.5%
- Non-GAAP EPS: USD 4.25 to 4.35
- Tariffs:
